Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Regis | RGS | Oct 15, 2024 | 26.69 | -0.93 |
Regulus Therapeutics | RGLS | Oct 15, 2024 | 1.50 | -1.32 |
Reinsurance Group of America | RGA | Oct 15, 2024 | 216.77 | -0.35 |
REIT Index ETF Vanguard | VNQ | Oct 15, 2024 | 96.50 | +1.21 |
Reitar Logtech | RITR | Oct 15, 2024 | 4.84 | 0.00 |
Rekor Systems | REKR | Oct 15, 2024 | 1.11 | -3.48 |
Relay Therapeutics | RLAY | Oct 15, 2024 | 6.74 | -0.15 |
Reliance | RS | Oct 15, 2024 | 290.82 | -0.97 |
Reliance Global | RELI | Oct 15, 2024 | 2.08 | -5.45 |
Relmada Therapeutics | RLMD | Oct 15, 2024 | 3.48 | +3.88 |
RELX ADR | RELX | Oct 15, 2024 | 48.22 | +1.77 |
Remitly Global | RELY | Oct 15, 2024 | 13.92 | +2.65 |
Renaissance Ipo ETF | IPO | Oct 15, 2024 | 43.55 | -1.78 |
RenaissanceRe | RNR | Oct 15, 2024 | 274.68 | -1.42 |
RenaissanceRe G Pref | RNR-G | Oct 15, 2024 | 18.56 | +0.65 |
RenaissanceRe Holding F Pref | RNR-F | Oct 15, 2024 | 24.40 | +0.31 |
Renalytix ADR | RNLX | Oct 15, 2024 | 0.20 | 0.00 |
Renasant | RNST | Oct 15, 2024 | 33.51 | +1.89 |
Reneo Pharmaceuticals | RPHM | Oct 15, 2024 | 1.82 | 0.00 |
ReNew Energy Global A Shares | RNW | Oct 15, 2024 | 5.88 | -0.84 |
Renn Fund | RCG | Oct 15, 2024 | 2.04 | -1.45 |
Renovaro Biosciences | RENB | Oct 15, 2024 | 0.71 | +28.40 |
RenovoRx | RNXT | Oct 15, 2024 | 0.99 | -0.99 |
Rent The Runway A | RENT | Oct 15, 2024 | 9.71 | -0.51 |
Rentokil Initial ADR | RTO | Oct 15, 2024 | 23.08 | -1.95 |
Repare Therapeutics | RPTX | Oct 15, 2024 | 3.36 | -0.89 |
Repay A | RPAY | Oct 15, 2024 | 7.80 | -2.13 |
Repligen | RGEN | Oct 15, 2024 | 144.98 | +1.35 |
Replimune Group | REPL | Oct 15, 2024 | 10.54 | -1.22 |
ReposiTrak | TRAK | Oct 15, 2024 | 20.04 | +4.21 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.